Increased plasma malondialdehyde and protein carbonyl levels and lymphocyte DNA damage in patients with angiographically defined coronary artery disease

Mutlu-Türkoglu, Ü.; Akalin, Zülal; Ilhan, Ebru; Yılmaz, Ercüment; Bilge, Ahmet Kaya; Nişanci, Yılmaz; Uysal, Müjdat

doi:10.1016/j.clinbiochem.2005.07.001

Cited by 48 publications

(36 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This finding suggested a relationship between hs-CRP and LDLcholesterol level and metabolic syndrome. Many studies have shown that change in the concentration of plasma lipids in CAD patients definitely contributed to development of vascular disease (7,31,35). In the present study, however, no significant association was found between PAI-1 gene polymorphism, and serum level of hs-CRP and risk of CAD.…”

Section: Discussioncontrasting

confidence: 55%

The Association between PAI-1 Gene Promoter Polymorphism and Serum Serpin E1, MDA, and Hs-CRP Levels in Coronary Artery Disease

Karimian

Farajnia

Ghojazadeh

et al. 2016

Int Cardiovasc Res J

View full text Add to dashboard Cite

A B S T R A C TBackground: Coronary artery disease (CAD) caused by atherosclerosis. Studies have shown that there are a number of factors which are closely related to the development and progression of CAD that include Cellular binding molecules like Plasminogen Activator Inhibitor-1(PAI-1), Lipid peroxidation, inflammation and hemostasis. Objectives: The present case-control study aimed to evaluate the association between Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G polymorphism and oxidative stress markers and Coronary Artery Disease (CAD). Patients and Methods: Blood was drawn and DNA was extracted from 90 subjects (46 patients with angiographically diagnosed CAD and 44 age-and sex-matched healthy controls). The 4G/5G polymorphism of PAI-1 was detected by Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) analysis. Besides, the risk factors, serpin E1, Malondialdehyde (MDA), high-sensitivity C-Reactive Protein (hs-CRP), and lipid profile serum levels were measured by standard methods and were compared between the two study groups using independent samples t-test, one-way ANOVA, and Mann-Whitney U test as appropriated. Results: Results: The frequency of 4G/4G genotype of PAI-1 gene was higher in the CAD patients than in the controls (28/46 (60.87%) vs. 8/44 (18.18%), P < 0.01). Additionally, the serpin E1 plasma level was significantly higher in the CAD group carrying the 4G allele compared to those homozygous for the 5G allele (P = 0.016). Besides, a significant difference was found between the 4G/4G and 5G/5G subjects of the CAD group regarding plasma High-Density Lipoprotein (HDL) (P < 0.01). Also, significant differences were observed among the three genotypes of both groups concerning the plasma levels of cholesterol, triglyceride, and Low-Density Lipoprotein (LDL). However, no significant correlation was found between PAI-1 gene polymorphism and MDA serum level, hs-CRP, and risk of CAD. Conclusion: The findings of this study suggested that 4G/4G PAI-1 polymorphism was associated with cholesterol, triglyceride, LDL, and HDL levels and could be regarded as a biomarker for risk of CAD. Our findings suggested that the 4G/5G polymorphism of the PAI-1 gene seems to be a useful marker of fibrinolytic activity. Besides, this polymorphism might contribute to defective fibrinolytic activity due to elevated PAI-1 plasma level, eventually increasing the risk of coronary artery disease. Moreover, the study results demonstrated that this genetic variation might be important in correlation with some other factors, such as increased or decreased triglyceride, cholesterol, and LDL and HDL levels. However, no significant correlation was observed between PAI-1 4G/5G gene polymorphism and serum levels of stress oxidative factors, such as MDA and hs-CRP.

show abstract

Section: Discussioncontrasting

confidence: 55%

The Association between PAI-1 Gene Promoter Polymorphism and Serum Serpin E1, MDA, and Hs-CRP Levels in Coronary Artery Disease

Karimian

Farajnia

Ghojazadeh

et al. 2016

Int Cardiovasc Res J

View full text Add to dashboard Cite

show abstract

“…Comet assay is a rapid, simple and sensitive technique for measuring DNA breaks and repair in single cells and has been used in various studies to investigate the effect of ROS on DNA [15][16][17].…”

Section: Dna Damage Evaluation By Comet Assaymentioning

confidence: 99%

Association of low repair efficiency with high hormone receptors expression and SOD activity in breast cancer patients

Agnoletto¹,

Guecheva²,

Dondé³

et al. 2007

Clinical Biochemistry

View full text Add to dashboard Cite

“…Oxidative stress parameters have been evaluated in CAD frequently (2,3). However, there has not been much published work related to oxidative stress in young CAD patients in India.…”

Section: Introductionmentioning

confidence: 99%

hs-CRP and oxidative stress in young CAD patients: A pilot study

Sharma

Garg

Veerwal

et al. 2008

Indian J Clin Biochem

View full text Add to dashboard Cite

show abstract

Increased plasma malondialdehyde and protein carbonyl levels and lymphocyte DNA damage in patients with angiographically defined coronary artery disease

Cited by 48 publications

References 37 publications

The Association between PAI-1 Gene Promoter Polymorphism and Serum Serpin E1, MDA, and Hs-CRP Levels in Coronary Artery Disease

The Association between PAI-1 Gene Promoter Polymorphism and Serum Serpin E1, MDA, and Hs-CRP Levels in Coronary Artery Disease

Association of low repair efficiency with high hormone receptors expression and SOD activity in breast cancer patients

hs-CRP and oxidative stress in young CAD patients: A pilot study

Contact Info

Product

Resources

About